Alcohol misuse is the leading cause of cirrhosis and the second most common indication for liver transplantation in the Western world 1-3 . We performed a genome-wide association study for alcohol-related cirrhosis in individuals of European descent (712 cases and 1,426 controls) with subsequent validation in two independent European cohorts (1,148 cases and 922 controls). We identified variants in the MBOAT7 (P = 1.03 × 10 −9 ) and TM6SF2 (P = 7.89 × 10 −10 ) genes as new risk loci and confirmed rs738409 in PNPLA3 as an important risk locus for alcohol-related cirrhosis (P = 1.54 × 10 −48 ) at a genomewide level of significance. These three loci have a role in lipid processing, suggesting that lipid turnover is important in the pathogenesis of alcohol-related cirrhosis.
l e t t e r s with alcohol-related cirrhosis (cases) to alcohol misusers without cirrhosis (controls).
In stage 1, GWAS were undertaken in separate German and UK cohorts. The first GWAS included 410 Germans with alcohol-related cirrhosis and 1,119 heavy drinkers without liver disease from a German psychiatric consortium 12 . The second GWAS included 302 cases and 346 controls from the UK ( Table 1) . We performed genotype imputation using IMPUTE2 (ref. 13 ) to the 1000 Genomes Project Phase 3 reference panel.
Meta-analysis was restricted to markers present in both data sets (n = 6,770,426). After genomic control (GC) adjustment, a λ value of 1.005 was obtained for the combined analysis (Supplementary Fig. 1 ). The resulting Manhattan plot is shown in Figure 1 . The strongest signal was at rs738409, located in PNPLA3 (P = 1.17 × 10 −28 ); 102 additional genome-wide significant SNPs (P meta < 5 × 10 −8 ) mapped to this locus (Supplementary Table 1 ).
In addition, we performed a secondary genome-wide metaanalysis, adjusted for age, sex, body mass index (BMI) and type 2 diabetes status, in 456 cases and 873 controls for whom complete covariate information was available (Supplementary Table 2 ). Genome-wide significance was attained only at the PNPLA3 locus (Supplementary Table 3 ). The Manhattan and quantile-quantile plots for this analysis are shown in Supplementary Figures 2 and 3 .
The presence of cirrhosis may directly affect BMI and blood sugar levels, and so these variables may not act as true disease confounders in this context. Consequently, adjusting the analysis for these variables may instead correct for the intended phenotype. Thus, the most significant variants from the top ten most strongly associated loci in the primary, unadjusted meta-analysis were carried forward to replication.
In stage 2, SNPs were validated in independent samples from Germany (n = 1,290) and Belgium (n = 779) ( Table 1) by fixed-effect meta-analysis. For a locus to be defined as independent, it was required to be separated from other loci by at least 500 kb of genomic distance (Supplementary Table 1 ). In addition to rs738409 in PNPLA3, we replicated disease association for variants rs626283 in MBOAT7 and rs10401969 in SUGP1 ( Table 2 ). In the combined analysis of all stage 1 and stage 2 samples, both newly identified replicating SNPs attained genome-wide significant evidence of association (MBOAT7: rs626283, P combined = 1.03 × 10 −9 , odds ratio (confidence interval) = 1.35 (1.23-1.49); SUGP1: rs10401969, P combined = 7.89 × 10 −10 , OR = 1.72 (1.44-2.04); Table 2 ) and mapped to distinct loci.
To assess the validity of the design choice made for the primary analysis, we performed a post-hoc analysis for the replicating variants adjusted for age, sex, BMI and type 2 diabetes status. The three loci remained significant in the adjusted analysis, and the odds ratios in the adjusted and unadjusted analyses were similar ( Table 3) . We genotyped the top ten loci from the adjusted GWAS meta-analysis (Supplementary Tables 3 and 4) in the cohorts outlined in Supplementary Table 2 . Only the rs738409 variant in PNPLA3 replicated, with a combined adjusted P value of 2.16 × 10 −26 (Supplementary Table 3 ).
The association of alcohol-related cirrhosis with the three validated loci was assessed for each of the three case cohorts (Germany, UK and Belgium) on a population level. The odds ratios for the presence of the risk allele in individuals from the general population were lower than those for heavy drinkers without liver disease: PNPLA3 (OR population = (Fig. 2) . Population-attributable risks (PARs) were calculated against population controls and controls drinking Table 5 ).
The strongest signal at the MBOAT7 locus was obtained for the imputed variant rs626283 (P = 1.07 × 10 −5 , OR = 1.36 (1.19-1.57)). The results from the meta-analysis (Fig. 3) identified a cluster of variants in high linkage disequilibrium (LD) covering the 5′ regions of the neighboring TMC4 and MBOAT7. Fine-mapping genotyping and conditional analysis using a total of 13 SNPs from the region confirmed the principal location of the association signal (Supplementary Table 6 ). The top MBOAT7 variant identified through fine mapping, rs641738, is in high LD with rs626283 (r 2 = 0.98). The strongest signal at the TM6SF2 locus was obtained for variant rs58542926 (P = 7.34 × 10 −5 , OR = 1.59 (1.26-1.99)), which is in complete LD with rs10401969 in SUGP1 ( Table 2 and Supplementary Fig. 4 ).
We performed cis expression quantitative trait locus (cis-eQTL) analyses for MBOAT7 using the genomic interval displayed in Figure 3 and publicly available human liver data sets 14 . MBOAT7 and TMC4 transcripts were both expressed in human liver ( Supplementary  Fig. 5 ). Variant rs641738 showed strong association with expression of MBOAT7 in the two data sets 14 (P expression = 1.17 × 10 −13 and 2.23 × 10 −3 ). We observed significant genotype-specific differential expression for the disease-associated allele in liver tissue from patients with alcohol-related cirrhosis for MBOAT7 (P = 0.0087) but not for the neighboring TMC4 (Supplementary Fig. 6 ).
This first genome-wide genetic assessment for alcohol-related cirrhosis confirmed the prominent role of PNPLA3-a gene identified first in a candidate gene association study 9 and confirmed in recent meta-analyses 15, 16 -but also identified two new genomewide significant loci, MBOAT7 and TM6SF2. Associations remained significant after adjustment for sex, age, BMI and type 2 diabetes status in a subset of patients (64%) for whom complete phenotype information was available. The observed unadjusted odds ratios for all three loci were similar to those corrected for potential confounding variables, supporting the relevance of these loci in risk for the development of alcohol-related cirrhosis. However, if the primary replication had been conducted as a fully adjusted analysis, the TM6SF2 locus would have been associated with a nominal P value of 0.020 and thus would not have reached Bonferronicorrected significance.
Other liver-related phenotypes, including NAFLD 7, 17 , chronic hepatitis C virus 18 , gallstone disease 19 , primary biliary cirrhosis 20 , primary sclerosing cholangitis 21 and drug-induced liver injury 22 , have been investigated on a genome-wide scale. The delay in the systematic investigation of alcohol-related cirrhosis is somewhat surprising. It may in part be due to the difficulties encountered in recruiting appropriate controls-namely, individuals misusing alcohol for prolonged periods of time but without evidence of alcohol-related liver injury. Very few studies have chosen such an approach 8, 9 . The importance of using long-term alcohol misusers as controls is underlined by the lower odds ratios for all three loci when compared with general population controls (Fig. 2) . In the current study, the risk loci for alcohol-related cirrhosis are clearly distinct from the reported loci for alcohol dependence, consumption and withdrawal symptoms 12, [23] [24] [25] [26] . Further, in candidate gene studies of ADH1B (encoding alcohol dehydrogenase 1B), ALDH2 (encoding aldehyde dehydrogenase 2) and GABRA2 (encoding γ-aminobutyric acid A receptor, α2), npg l e t t e r s there is no evidence of association with alcohol-related liver disease 27 , suggesting that the genetic risk factors for alcohol dependence and alcohol-related cirrhosis are distinct. Genetic variation at PNPLA3 has been established as a risk factor for alcohol-related cirrhosis in previous studies 8, 9 and meta-analyses 15, 16 , and the functional relevance of the nonsynonymous variant rs738409 has been explored 10, 11, 28 . Data from the present study underline the importance of this variant on a genome-wide level.
One of the other top hits identified in this study, rs641738, is located in the 19q13.42 region and contains TMC4 and MBOAT7. Analysis of eQTL data sets indicates that the lead variant is associated with variation in MBOAT7 expression 14 and that this variant is associated with genotype-specific expression in liver tissue from patients with alcoholrelated cirrhosis (Supplementary Fig. 6 ). These data implicate rs641738 as a candidate functional variant influencing the expression of MBOAT7 and alcohol-related cirrhosis risk. MBOAT7 encodes an enzyme with lysophosphatidylinositol acyltransferase activity and has been implicated in anti-inflammatory processes through regulating arachidonic acid levels in neutrophils 29 . In rat liver microsomes, MBOAT7 catalyzes the transfer of fatty acid between phospholipids and lysophospholipids 30 , a potent driver mechanism of hepatic inflammation. A key molecular product of this enzymatic reaction Figure 2 Forest plots of odds ratios and 95% confidence intervals for the susceptibility loci for alcohol-related cirrhosis in comparison to alcohol misusers and population controls. Data were generated using the rmeta package in R. Figure 3 Fine-mapping analysis of the MBOAT7 association signals. The −log 10 (P values) are plotted against SNP genomic position based on NCBI Build 37. Squares denote genotyped SNPs; circles denote imputed SNPs (obtained using 1000 Genomes Project-based imputation). SNPs are colored to reflect correlation with the most significant SNP, with red denoting the highest LD (r 2 >0.8) with the lead SNP. Estimated recombination rates from the 1000 Genomes Project (hg19/genomes March 2012 release, EUR population) are plotted in blue to reflect the local LD structure. Gene annotations were obtained from the UCSC Genome Browser. The plot was generated using LocusZoom 40 . npg l e t t e r s is sensed by GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity 31 , thus providing a link between MBOAT7 and the known role of the endocannabinoid system in hepatic extracellular matrix remodeling 32, 33 . These functional observations provide a hypothetical mechanism through which the identified variant in MBOAT7 may modulate inflammation-driven liver fibrogenesis in alcohol-related liver injury. The final top hit identified in the present study, rs58542926, is a coding variant (p.Glu167Lys) in TM6SF2, which is a reported risk factor for NAFLD phenotypes 17, 34 , and a protective factor against cardiovascular disease 35 . At a functional level, TM6SF2 activity is required for very-low-density lipoprotein secretion, and the identified risk variant might result in impaired biological function, causing hepatic lipid trapping and hence steatosis 17 . PNPLA3 and TM6SF2 contain functional variants that associate with both alcohol-related and obesity-related liver disease, demonstrating a striking similarity in their heritability that echoes similarities in their clinical presentation and histopathology.
A previous GWAS of NAFLD identified a significant association between liver histology and a variant in NCAN (encoding neurocan) 36 , but two subsequent GWAS demonstrated that the associations localized to variants within a neighboring gene, TM6SF2, rather than NCAN 17, 34 . A recent candidate gene study from our group found an association between the NCAN rs2228603 variant and hepatocellular carcinoma 37 but not cirrhosis per se, most likely because rs2228603 is not the true risk variant for cirrhosis.
In conclusion, the present study confirms PNPLA3 as a risk locus for alcohol-related cirrhosis and identifies TM6SF2 and MBOAT7 as additional risk loci. All three genes are functionally annotated as being involved in lipid metabolic processes. It is known that variants in both PNPLA3 and TM6SF2 are associated with increases in intrahepatic fat compatible with loss of function leading to lipid trapping within hepatocytes 10 . Thus, we hypothesize that the genetic variants in these loci confer risk via dysfunctional lipid turnover. Further research is needed to determine whether the fine-mapping studies have identified the variants underlying the functional variability in the encoded protein.
The top hits for alcohol-related cirrhosis overlap with those identified as risk factors for NAFLD, implying that these conditions share mechanisms of pathogenesis and that the risk-associated genes may be therapeutic targets in both disorders. The variants at the three identified loci may also help to define high-risk populations for targeted abstinence intervention and hepatic surveillance programs 38, 39 .
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